Review



human ace2  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Sino Biological human ace2
    Human Ace2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 32 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Human+ACE2+%2F+Angiotensin-Converting+Enzyme+2+Protein/pmc13753715-269-7-9
    Average 96 stars, based on 32 article reviews
    human ace2 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    96 Well Plates:

    Article Title: A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.
    Article Snippet: it continues to spread worldwide and has been regarded as the most infectious agent in a century [1].. As of May 2025, more than 777 million confirmed cases and more than 7 million deaths have been reported due to COVID-19 (WHO COVID-19 Dashboard) [2].. The World Health Organisation (WHO) has authorized several vaccines to immunize the population around the globe and prevent the spread of the virus to reduce the need for therapeutics.

    Blocking Assay:

    Article Title: Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells
    Article Snippet: .. Then, the cells were permeabilized with 0.1% Triton-X 100 in PBS for 15 min at 37 °C and blocked with 2% bovine serum albumin in PBS (blocking solution) for 1 h. Primary antibodies, including SARS-CoV-2 nucleocapsid (1:200, Sino Biological (40143-R001)), OCT4 (1:200, Santa Cruz Biotechnology (SC5279)), SSEA4 (1:200, Santa Cruz Biotechnology (SC59368)), Nanog (1:200, Santa Cruz Biotechnology (SC33759)), Tra-1-60 (1:200, Santa Cruz Biotechnology (SC21705)), Nestin (1:200, Cell Signaling (33475)), Tuj1 (1:200, Santa Cruz Biotechnology (SC51670)), GFAP (1:100, Abcam (ab190288)), S100β (1:100, Abcam (ab52642)), NF-kB (1:200, Cell Signaling (8242)) and ACE2 (1:200, Sino Biological (10108-T24)) were diluted in blocking solution and incubated overnight at 4 °C. ..

    Article Title: Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells.
    Article Snippet: .. Primary antibodies, including SARS-CoV2 nucleocapsid (1:200, Sino Biological (40143-R001)), OCT4 (1:200, Santa Cruz Biotechnology (SC5279)), SSEA4 (1:200, Santa Cruz Biotechnology (SC59368)), Nanog (1:200, Santa Cruz Biotechnology (SC33759)), Tra-1-60 (1:200, Santa Cruz Biotechnology (SC21705)), Nestin AR TIC LE IN PR ES S (1:200, Cell Signaling (33475)), Tuj1 (1:200, Santa Cruz Biotechnology (SC51670)), GFAP (1:100, Abcam (ab190288)), S100β (1:100, Abcam (ab52642)), NF-B (1:200, Cell Signaling (8242)) and ACE2 (1:200, Sino Biological (10108-T24)) were diluted in blocking solution and incubated overnight at 4 °C. ..

    Incubation:

    Article Title: Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells
    Article Snippet: .. Then, the cells were permeabilized with 0.1% Triton-X 100 in PBS for 15 min at 37 °C and blocked with 2% bovine serum albumin in PBS (blocking solution) for 1 h. Primary antibodies, including SARS-CoV-2 nucleocapsid (1:200, Sino Biological (40143-R001)), OCT4 (1:200, Santa Cruz Biotechnology (SC5279)), SSEA4 (1:200, Santa Cruz Biotechnology (SC59368)), Nanog (1:200, Santa Cruz Biotechnology (SC33759)), Tra-1-60 (1:200, Santa Cruz Biotechnology (SC21705)), Nestin (1:200, Cell Signaling (33475)), Tuj1 (1:200, Santa Cruz Biotechnology (SC51670)), GFAP (1:100, Abcam (ab190288)), S100β (1:100, Abcam (ab52642)), NF-kB (1:200, Cell Signaling (8242)) and ACE2 (1:200, Sino Biological (10108-T24)) were diluted in blocking solution and incubated overnight at 4 °C. ..

    Article Title: Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells.
    Article Snippet: .. Primary antibodies, including SARS-CoV2 nucleocapsid (1:200, Sino Biological (40143-R001)), OCT4 (1:200, Santa Cruz Biotechnology (SC5279)), SSEA4 (1:200, Santa Cruz Biotechnology (SC59368)), Nanog (1:200, Santa Cruz Biotechnology (SC33759)), Tra-1-60 (1:200, Santa Cruz Biotechnology (SC21705)), Nestin AR TIC LE IN PR ES S (1:200, Cell Signaling (33475)), Tuj1 (1:200, Santa Cruz Biotechnology (SC51670)), GFAP (1:100, Abcam (ab190288)), S100β (1:100, Abcam (ab52642)), NF-B (1:200, Cell Signaling (8242)) and ACE2 (1:200, Sino Biological (10108-T24)) were diluted in blocking solution and incubated overnight at 4 °C. ..

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4°C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H+L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4 °C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H + L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.

    Control:

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4°C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H+L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4 °C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H + L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.

    Knock-Out:

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4°C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H+L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.

    Article Title: UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN
    Article Snippet: Cells were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and images were captured using a Leica TCS SP8 confocal microscope and processed using Leica Application Suite X (LAS X, v3.7.0.20979) and ImageJ v2.0.0 ( http://rsb.info.nih.gov/ij/ ). .. Control and UHRF1 -knockout A549 cells were detached with TrypLE and incubated with primary antibodies against APN (Invitrogen #14-0138-82, 1 μg/ml), heparan sulfate (10E4) (USBiological #H1890, 1 μg/ml), ACE2 (Sino Biological #10108-RP01, 1:250), DC-SIGN (Biolegend #330102, 1 μg/ml), or TIM-1 (Biolegend #354002, 1 μg/ml) at 4 °C for 25 minutes. .. After washing, cells were stained with goat anti-mouse or rabbit IgG (H + L) conjugated with Alexa Fluor 647 (Thermo Fisher #A21245, 2 μg/ml) for 25 minutes at 4 °C and analyzed by flow cytometry.



    Similar Products

    96
    Sino Biological human ace2
    Human Ace2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Human+ACE2+%2F+Angiotensin-Converting+Enzyme+2+Protein/pmc13753715-269-7-9
    Average 96 stars, based on 1 article reviews
    human ace2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    R&D Systems angiotensin converting enzyme 2 ace2
    The effect of 7g .HCl on the activity of peptidases closely related to Nln. Concentration-response curves of the Nln-related zinc-metallopeptidases A) TOP, B) NEP, C) ACE and D) <t>ACE2</t> activity in the presence of 7g (0.1 to 300 μM). Enzyme activity was monitored by the hydrolysis of fluorogenic substrates described in the Methods. Basal activity of all enzymes corresponds to 100% on the vertical axis and is the same as vehicle control (n = 4). An additional one-way ANOVA followed by Dunnett’s multiple comparisons test was conducted to determine the statistical significance of 7g .HCl’s effect on ACE2 activity (13% activation at 100 μM, 28% activation at 300 μM; ***P < .001 compared with basal activity).
    Angiotensin Converting Enzyme 2 Ace2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Recombinant+Human+ACE-2+Protein%2C+CF/pmc13764097-645-11-28
    Average 95 stars, based on 1 article reviews
    angiotensin converting enzyme 2 ace2 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    InvivoGen human lung carcinoma a549 cells expressing ace2
    ( A ) Chemical structures of EDA and MeDA. ( B - C ) Inhibition of HCoV-229E and cytotoxicity in HEL299 cells, based on cell viability assay (panel B ), or assessment of viral load and infectious titer (panel C ). ( D ) Anti-HCoV-229E activity in human bronchial 16HBE cells. ( E - G ) Inhibition of SARS-CoV-2 and cytotoxicity, based on cell viability assay in <t>A549</t> <t>ACE2/TMPRSS2</t> (A549A/T) cells (panel E ); immunostaining for viral dsRNA in human bronchial Calu-3 cells (panel F ); or determination of viral load in primary human nasal cells grown at air-liquid interface (panel G ). Data in panels B-G are mean values ± SEM (N=3-5 except for: panel E, where N=10; and panel G, where N=2-3). ( H ) Compilation of the anti-CoV activity values of EDA, MeDA, GS-441524 and NHC, across different CoVs and cell models. Symbols: EC 50 or EC 99 values, depending on the assay readout, from 2-13 independent tests; black bar: mean value.
    Human Lung Carcinoma A549 Cells Expressing Ace2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/A549-Dual+hACE2-TMPRSS2+Cells/bio_rxiv__64898__2026__10__28__761875-211-1-16
    Average 99 stars, based on 1 article reviews
    human lung carcinoma a549 cells expressing ace2 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC hela ace2 66 raw264 7 cells
    ( A ) Chemical structures of EDA and MeDA. ( B - C ) Inhibition of HCoV-229E and cytotoxicity in HEL299 cells, based on cell viability assay (panel B ), or assessment of viral load and infectious titer (panel C ). ( D ) Anti-HCoV-229E activity in human bronchial 16HBE cells. ( E - G ) Inhibition of SARS-CoV-2 and cytotoxicity, based on cell viability assay in <t>A549</t> <t>ACE2/TMPRSS2</t> (A549A/T) cells (panel E ); immunostaining for viral dsRNA in human bronchial Calu-3 cells (panel F ); or determination of viral load in primary human nasal cells grown at air-liquid interface (panel G ). Data in panels B-G are mean values ± SEM (N=3-5 except for: panel E, where N=10; and panel G, where N=2-3). ( H ) Compilation of the anti-CoV activity values of EDA, MeDA, GS-441524 and NHC, across different CoVs and cell models. Symbols: EC 50 or EC 99 values, depending on the assay readout, from 2-13 independent tests; black bar: mean value.
    Hela Ace2 66 Raw264 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/RAW+264%2E7/pm42956738-689-5-8
    Average 99 stars, based on 1 article reviews
    hela ace2 66 raw264 7 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    R&D Systems ace2
    COVID-19 Induces <t>ACE2</t> Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.
    Ace2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Human%2FMouse%2FRat%2FHamster+ACE-2+Antibody/pmc13749090-37-25-27
    Average 96 stars, based on 1 article reviews
    ace2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Shanghai Korain Biotech Co Ltd ace2 activity assay kit
    COVID-19 Induces <t>ACE2</t> Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.
    Ace2 Activity Assay Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Rat+Angiotensin+Converting+Enzyme+2/pm42908280-92-49-68
    Average 94 stars, based on 1 article reviews
    ace2 activity assay kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    ACROBiosystems biotinylated human ace2
    COVID-19 Induces <t>ACE2</t> Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.
    Biotinylated Human Ace2, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Biotinylated+Human+ACE2+%2F+ACEH+Protein%2C+His%2CAvitag/pm42913748-100-15-21
    Average 95 stars, based on 1 article reviews
    biotinylated human ace2 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Proteintech ace2
    COVID-19 Induces <t>ACE2</t> Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.
    Ace2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2+Polyclonal+antibody/pm42892631-104-16-17
    Average 94 stars, based on 1 article reviews
    ace2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    ATCC cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s
    COVID-19 Induces <t>ACE2</t> Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.
    Cell Lines 293t Cells Atcc Crl 3216 Bhk 21 Cells Atcc Ccl 10 Oligonucleotides Miniopterus Ace2 Point Mutation Primer S, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/BHK-21/pm42876586-161-15-19
    Average 99 stars, based on 1 article reviews
    cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology ace2
    Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, <t>ACE2,</t> or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).
    Ace2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2+siRNA/pmc13659286-221-5-9
    Average 94 stars, based on 1 article reviews
    ace2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    The effect of 7g .HCl on the activity of peptidases closely related to Nln. Concentration-response curves of the Nln-related zinc-metallopeptidases A) TOP, B) NEP, C) ACE and D) ACE2 activity in the presence of 7g (0.1 to 300 μM). Enzyme activity was monitored by the hydrolysis of fluorogenic substrates described in the Methods. Basal activity of all enzymes corresponds to 100% on the vertical axis and is the same as vehicle control (n = 4). An additional one-way ANOVA followed by Dunnett’s multiple comparisons test was conducted to determine the statistical significance of 7g .HCl’s effect on ACE2 activity (13% activation at 100 μM, 28% activation at 300 μM; ***P < .001 compared with basal activity).

    Journal: Journal of medicinal chemistry

    Article Title: Discovery of Neurolysin Activators with Preclinical Efficacy in an Ischemic Stroke Model

    doi: 10.1021/acs.jmedchem.6c02108

    Figure Lengend Snippet: The effect of 7g .HCl on the activity of peptidases closely related to Nln. Concentration-response curves of the Nln-related zinc-metallopeptidases A) TOP, B) NEP, C) ACE and D) ACE2 activity in the presence of 7g (0.1 to 300 μM). Enzyme activity was monitored by the hydrolysis of fluorogenic substrates described in the Methods. Basal activity of all enzymes corresponds to 100% on the vertical axis and is the same as vehicle control (n = 4). An additional one-way ANOVA followed by Dunnett’s multiple comparisons test was conducted to determine the statistical significance of 7g .HCl’s effect on ACE2 activity (13% activation at 100 μM, 28% activation at 300 μM; ***P < .001 compared with basal activity).

    Article Snippet: 36 , 37 Human angiotensin converting enzyme (ACE; product # 929-ZN), angiotensin converting enzyme 2 (ACE2) (product # 933-ZN), and neprilysin (NEP; product # 1182-ZNC) were obtained from R&D Systems (Minneapolis, MN).

    Techniques: Activity Assay, Concentration Assay, Control, Activation Assay

    ( A ) Chemical structures of EDA and MeDA. ( B - C ) Inhibition of HCoV-229E and cytotoxicity in HEL299 cells, based on cell viability assay (panel B ), or assessment of viral load and infectious titer (panel C ). ( D ) Anti-HCoV-229E activity in human bronchial 16HBE cells. ( E - G ) Inhibition of SARS-CoV-2 and cytotoxicity, based on cell viability assay in A549 ACE2/TMPRSS2 (A549A/T) cells (panel E ); immunostaining for viral dsRNA in human bronchial Calu-3 cells (panel F ); or determination of viral load in primary human nasal cells grown at air-liquid interface (panel G ). Data in panels B-G are mean values ± SEM (N=3-5 except for: panel E, where N=10; and panel G, where N=2-3). ( H ) Compilation of the anti-CoV activity values of EDA, MeDA, GS-441524 and NHC, across different CoVs and cell models. Symbols: EC 50 or EC 99 values, depending on the assay readout, from 2-13 independent tests; black bar: mean value.

    Journal: bioRxiv

    Article Title: Mechanistic insights into coronavirus polymerase inhibition by a base-modified adenosine analog

    doi: 10.64898/2026.10.28.761875

    Figure Lengend Snippet: ( A ) Chemical structures of EDA and MeDA. ( B - C ) Inhibition of HCoV-229E and cytotoxicity in HEL299 cells, based on cell viability assay (panel B ), or assessment of viral load and infectious titer (panel C ). ( D ) Anti-HCoV-229E activity in human bronchial 16HBE cells. ( E - G ) Inhibition of SARS-CoV-2 and cytotoxicity, based on cell viability assay in A549 ACE2/TMPRSS2 (A549A/T) cells (panel E ); immunostaining for viral dsRNA in human bronchial Calu-3 cells (panel F ); or determination of viral load in primary human nasal cells grown at air-liquid interface (panel G ). Data in panels B-G are mean values ± SEM (N=3-5 except for: panel E, where N=10; and panel G, where N=2-3). ( H ) Compilation of the anti-CoV activity values of EDA, MeDA, GS-441524 and NHC, across different CoVs and cell models. Symbols: EC 50 or EC 99 values, depending on the assay readout, from 2-13 independent tests; black bar: mean value.

    Article Snippet: Finally, human lung carcinoma A549 cells expressing ACE2 and TMPRSS2 (A549 ACE2/TMPRSS2 ) were purchased from InvivoGen (No. a549d-cov2r) and cultured in DMEM supplemented with 10% FCS; 6 mM L-glutamine; 25 mM glucose; 100 μg/ml hygromycin and 0.5 μg/ml puromycin.

    Techniques: Inhibition, Cell Viability Assay, Activity Assay, Immunostaining, Quantitative RT-PCR

    COVID-19 Induces ACE2 Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet: COVID-19 Induces ACE2 Loss via Viral Infection and ADAM17 Activation (A) Patient with (COVID-19) plasma and tissue samples were collected during hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to study the pathophysiology of the disease. (B) Soluble angiotensin-converting enzyme 2 (sACE2), tumor necrosis factor-alpha (TNFα), soluble tumor necrosis factor receptor I (sTNFRI) and II (sTNFRII) in COVID-19 patient plasma with (+) and without (−) diabetes mellitus (DM) and obesity. (control patients, n = 45; COVID-19 patients without (−) DM and obesity, n = 82; COVID-19 patients with (+) DM and obesity, n = 82). (C) Hematoxylin and eosin (H&E), Masson's trichrome (MT), and ACE2 immunohistochemistry of heart (biological replicates = 4-8), small intestine (biological replicates = 8-9), kidney (biological replicates = 7-8), and liver (biological replicates = 4) samples. Arrows point to ACE2 +ve staining. Cardiac ACE2 panels include zoom-ins. (D) ACE2 +ve immunohistochemistry quantification as a percentage of total image area. (E) Myocardial fibrosis quantification (biological replicates = 4-7). (F) Immunofluorescent staining of human embryonic kidney (HEK) 293T cells overexpressing human ACE2 (human angiotensin-converting enzyme 2 [hACE2]) infected with SARS-CoV-2 for 36 hrs with or without ‘a disintegrin and metalloprotease 17’ (ADAM17) inhibitor TMI-2 (100 nM) or placebo (Pbo) treatment. Nuclear DAPI (4′,6-diamidino-2-phenylindole; blue), SARS-CoV-2 nucleocapsid (red) and ACE2 (green) staining and overlay image (scale bar 100 μm). (G to H) Quantification of ACE2 and SARS-CoV-2 nucleocapsid positive staining regions (biological replicates = 4). HEK 293T–hACE2 cells pretreated with ADAM17 inhibitor TMI-2 (100 nM) or placebo (Pbo) and infected with SARS-CoV-2 for 2 hours, followed by media washout and culturing with or without TMI-2 (100 nM) (same protocol as I-L). (I) ADAM17 activity of infected cells with or without ADAM17 inhibition at 36 hrs postinfection (biological replicates = 4, technical replicates = 3). (J to K) ACE2 immunoblots (2 bands) from infected cells and quantification of 36-48 hrs postinfection bands (biological replicates = 16). MemCode protein loading control. (L) TaqMan RT-polymerase chain reaction (qPCR) of ACE2 at 36 hrs postinfection (biological replicates = 2-3). Box plots represent median (IQR) and Kruskal-Wallis statistical testing (B); bar plots represent mean ± SD with Student's t -test D to E and analysis of variance (ANOVA) with Tukey post hoc statistical testing (G-L). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Infection, Activation Assay, Clinical Proteomics, Tissue, Control, Masson's Trichrome Staining, Immunohistochemistry, Staining, Activity Assay, Inhibition, Western Blot, Polymerase Chain Reaction, Analysis

    SARS-CoV-2 Infection Disrupts Enteric ACE2/B 0 AT1 With Plasma Metabolites Reflecting ACE2 Knockout and COVID-19 Patterns (A) Small intestine staining nuclear DAPI (blue), sodium-dependent neutral amino acid transporter (B 0 AT1, red), ACE2 (green), overlay (50 μm scale bar) and higher magnification (scale bar 20 μm) along with ACE2 knockout ( Ace2 -/y , turquoise) and double mutant (DMT, db/db Ace2 -/y , pink) controls. Genetic knockout of ACE2 leads to loss of B 0 AT1 translocation to the microvilli epithelial surface in Ace2 -/y and DMT mice. (B) ACE2 +ve villi staining area (biological replicates = 4-5). (C) Colocalization of B 0 AT1 and ACE2 villi signals (biological replicates = 4-5). (D) Small intestine ACE2 immunoblotting (1-3 bands) and quantification (biological replicates = 3). (E) Principal component analysis (PCA) of infected mouse plasma metabolomes (biological replicates = 4-6). 542 metabolites assessed. (F) Pathway enrichment analysis of plasma differentially expressed metabolites (DEMs) in day 7 infected db/db and WT mice. (G) Venn diagrams of increased and decreased plasma DEMs common between Ace2 -/y and WT infected animals and between DMT and db/db infected mice. (H) Infected mice, ACE2-depleted mice, and acute patients with COVID-19 plasma metabolites: tryptophan, serotonin, and taurine. MemCode protein loading control; day 2 and day 7 indicate post-infection mice. Bar and dot plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B to D and H; box plots represent median (IQR) with Mann-Whitney U statistical testing (H clinical data). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet: SARS-CoV-2 Infection Disrupts Enteric ACE2/B 0 AT1 With Plasma Metabolites Reflecting ACE2 Knockout and COVID-19 Patterns (A) Small intestine staining nuclear DAPI (blue), sodium-dependent neutral amino acid transporter (B 0 AT1, red), ACE2 (green), overlay (50 μm scale bar) and higher magnification (scale bar 20 μm) along with ACE2 knockout ( Ace2 -/y , turquoise) and double mutant (DMT, db/db Ace2 -/y , pink) controls. Genetic knockout of ACE2 leads to loss of B 0 AT1 translocation to the microvilli epithelial surface in Ace2 -/y and DMT mice. (B) ACE2 +ve villi staining area (biological replicates = 4-5). (C) Colocalization of B 0 AT1 and ACE2 villi signals (biological replicates = 4-5). (D) Small intestine ACE2 immunoblotting (1-3 bands) and quantification (biological replicates = 3). (E) Principal component analysis (PCA) of infected mouse plasma metabolomes (biological replicates = 4-6). 542 metabolites assessed. (F) Pathway enrichment analysis of plasma differentially expressed metabolites (DEMs) in day 7 infected db/db and WT mice. (G) Venn diagrams of increased and decreased plasma DEMs common between Ace2 -/y and WT infected animals and between DMT and db/db infected mice. (H) Infected mice, ACE2-depleted mice, and acute patients with COVID-19 plasma metabolites: tryptophan, serotonin, and taurine. MemCode protein loading control; day 2 and day 7 indicate post-infection mice. Bar and dot plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B to D and H; box plots represent median (IQR) with Mann-Whitney U statistical testing (H clinical data). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Infection, Clinical Proteomics, Knock-Out, Staining, Mutagenesis, Gene Knockout, Translocation Assay, Western Blot, Analysis, Control, MANN-WHITNEY

    ACE2 Disruption is Linked to Gut Barrier Dysfunction, Microbiota Changes, and Neurobehavioral Impairment (A) Microvilli plasmalemma vesicle-associated protein-1 (PV-1, green), zonula occludens-1 (ZO-1, green), and nuclear DAPI (blue) staining (scale bars 20 μm). (B) PV-1 +ve , ZO-1 +ve microvilli staining quantification (biological replicates = 5). (C to D) Plasma peptidoglycan (PGN) and intestinal fatty acid-binding protein (I-FABP) levels (biological replicates = 8). (E) Partial Least Squares Discriminant Analysis (PLS-DA) of metatranscriptomics functional profiles (biological replicates = 4). (F) Linear Discriminant Analysis Effect Size (LEfSe) of KEGG pathways enriched by metatranscriptomics in comparison between db/db and DMT, with linear discriminant analysis (LDA) scores >2 considered significant. (G) Fecal metabolites phenylacetic acid (PAA), tryptophan, indoleacetic acid, and kynurenic acid (biological replicates = 8). (H) Post–COVID-19 condition patient with PCC symptoms at 12-month follow-up (%). (I) Linear Discriminant Analysis Effect Size (LEfSe) comparison of intestinal microbiome signatures between COVID-19 negative (COVIDNEG; n = 10) and patients with PCC (n = 50). (J) LEfSe of enriched microbiota populations in Ace2 -/y and DMT mice. Linear discriminant analysis (LDA) scores >2 considered significant. (K) Open field test representative individual heatmap images. Red heatmap color indicates more time spent in location relative to individual traces. (L) Time in center (zero values do not show on log scale x-axis) and total distance traveled (biological replicates = 7). DMT, double mutant, db/db Ace2 -/y ; day 2 and day 7 indicate post-infection mice. Bar and dot plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B to E, G and L. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet: ACE2 Disruption is Linked to Gut Barrier Dysfunction, Microbiota Changes, and Neurobehavioral Impairment (A) Microvilli plasmalemma vesicle-associated protein-1 (PV-1, green), zonula occludens-1 (ZO-1, green), and nuclear DAPI (blue) staining (scale bars 20 μm). (B) PV-1 +ve , ZO-1 +ve microvilli staining quantification (biological replicates = 5). (C to D) Plasma peptidoglycan (PGN) and intestinal fatty acid-binding protein (I-FABP) levels (biological replicates = 8). (E) Partial Least Squares Discriminant Analysis (PLS-DA) of metatranscriptomics functional profiles (biological replicates = 4). (F) Linear Discriminant Analysis Effect Size (LEfSe) of KEGG pathways enriched by metatranscriptomics in comparison between db/db and DMT, with linear discriminant analysis (LDA) scores >2 considered significant. (G) Fecal metabolites phenylacetic acid (PAA), tryptophan, indoleacetic acid, and kynurenic acid (biological replicates = 8). (H) Post–COVID-19 condition patient with PCC symptoms at 12-month follow-up (%). (I) Linear Discriminant Analysis Effect Size (LEfSe) comparison of intestinal microbiome signatures between COVID-19 negative (COVIDNEG; n = 10) and patients with PCC (n = 50). (J) LEfSe of enriched microbiota populations in Ace2 -/y and DMT mice. Linear discriminant analysis (LDA) scores >2 considered significant. (K) Open field test representative individual heatmap images. Red heatmap color indicates more time spent in location relative to individual traces. (L) Time in center (zero values do not show on log scale x-axis) and total distance traveled (biological replicates = 7). DMT, double mutant, db/db Ace2 -/y ; day 2 and day 7 indicate post-infection mice. Bar and dot plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B to E, G and L. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Disruption, Staining, Clinical Proteomics, Binding Assay, Analysis, Functional Assay, Comparison, Microbiome, Open Field Test, Mutagenesis, Infection

    ACE2 Loss Worsens Cardiovascular Function in Obesity and Diabetes (A) Wheat germ agglutin (WGA, green) and nuclear DAPI (blue) staining highlighting cardiomyocytes (scale bar 100 μm large panel; 25 μm small panel), picrosirius red (PSR) staining of collagen deposition (scale bar 200 μm), Oil Red O (ORO) staining of triglycerides (scale bar 100 μm), dihydroethidium (DHE) staining of reactive oxygen species (ROS) presence (scale bar 100 μm). (B to C) Heart weights adjusted to tibial length (biological replicates = 20) and cardiac myocyte cross-sectional area (MCSA) (biological replicates = 6, technical replicates = 45). (D) Myocardial collagen deposition quantification based on PSR staining (biological replicates = 6, technical replicates = 14). (E) Triacylglycerol (TAG) content assay (biological replicates = 6). (F) DHE positive staining (biological replicates = 5). (G) NADPH oxidase activity with diphenyleneiodonium chloride (DPI) and ds-tat quenching (biological replicates = 6). (H) Transthoracic echocardiography left ventricle M-mode and tissue Doppler representative images. (I) Echocardiography early diastolic transmitral flow velocity/early diastolic mitral annular velocity (E/E′) ratio and left atrium (LA) diameter (biological replicates = 12). (J) Intubated, closed chest pressure-volume loop end-diastolic pressure (EDP), cardiac output (CO), and Tau (biological replicates = 9-10). (K) Ex vivo mesenteric artery acetylcholine-stimulated vasodilatory relaxation (biological replicates = 3-4, technical replicates = 2-5). (L to M) DHE aortic staining for ROS (scale bar 100 μm) and quantification. Arrows indicate luminal surface (biological replicates = 5). (N) Diastolic (DBP), systolic (SBP), and mean arterial blood pressures (MABP; biological replicates = 10-14). A.U. = arbitrary units; RLU = relative luminescent units. Bar plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet: ACE2 Loss Worsens Cardiovascular Function in Obesity and Diabetes (A) Wheat germ agglutin (WGA, green) and nuclear DAPI (blue) staining highlighting cardiomyocytes (scale bar 100 μm large panel; 25 μm small panel), picrosirius red (PSR) staining of collagen deposition (scale bar 200 μm), Oil Red O (ORO) staining of triglycerides (scale bar 100 μm), dihydroethidium (DHE) staining of reactive oxygen species (ROS) presence (scale bar 100 μm). (B to C) Heart weights adjusted to tibial length (biological replicates = 20) and cardiac myocyte cross-sectional area (MCSA) (biological replicates = 6, technical replicates = 45). (D) Myocardial collagen deposition quantification based on PSR staining (biological replicates = 6, technical replicates = 14). (E) Triacylglycerol (TAG) content assay (biological replicates = 6). (F) DHE positive staining (biological replicates = 5). (G) NADPH oxidase activity with diphenyleneiodonium chloride (DPI) and ds-tat quenching (biological replicates = 6). (H) Transthoracic echocardiography left ventricle M-mode and tissue Doppler representative images. (I) Echocardiography early diastolic transmitral flow velocity/early diastolic mitral annular velocity (E/E′) ratio and left atrium (LA) diameter (biological replicates = 12). (J) Intubated, closed chest pressure-volume loop end-diastolic pressure (EDP), cardiac output (CO), and Tau (biological replicates = 9-10). (K) Ex vivo mesenteric artery acetylcholine-stimulated vasodilatory relaxation (biological replicates = 3-4, technical replicates = 2-5). (L to M) DHE aortic staining for ROS (scale bar 100 μm) and quantification. Arrows indicate luminal surface (biological replicates = 5). (N) Diastolic (DBP), systolic (SBP), and mean arterial blood pressures (MABP; biological replicates = 10-14). A.U. = arbitrary units; RLU = relative luminescent units. Bar plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown.

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Staining, ROS Assay, Activity Assay, Echocardiography, Tissue, Ex Vivo

    SARS-CoV-2 Infection Alters Cardiac Gene Expression (A to B) Macrophages (CD68 +ve ) immunohistochemistry and quantification (count/mm 2 , biological replicates = 5) and Picrosirius red (PSR) staining of collagen deposition (biological replicates = 6). (C) SARS-CoV-2 nucleocapsid-positive staining regions (arrows) in infected mouse hearts. (D) Cardiac ACE2 immunoblot (1 band) and quantification (biological replicates = 5-7). (E) Cardiac bulk-RNA sequencing principal component analysis (PCA) of genes from mock and day 7 postinfection WT and db/db mice (biological replicates = 5-7). (F) Volcano plots of differentially expressed genes (DEGs) in WT vs db/db mock, WT infected vs mock, db/db infected vs mock, and infected db/db vs infected WT. (G) Apelin ( Apln ), apelin receptor ( Aplnr ), and (H) taurine transporter ( Slc6A6 ) expression levels. (I) Expression levels of SARS-CoV-2 entry-related enzymes: TMPRSS2 ( Tmprss2 ), cathepsin B ( Ctsb ), and furin ( Furin ). (J) Expression pattern of interleukin-34 ( Il34 ), transforming growth factor β ( Tgfb1 ), and inhibitor of kappa B alpha (IκBα) repressor ( Nfkbia ). MemCode protein loading control. FPKM, Fragments Per Kilobase of transcript per Million mapped reads; day 2 and day 7 indicate post-infection mice. Bar plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B and D, G to J. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown..

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet: SARS-CoV-2 Infection Alters Cardiac Gene Expression (A to B) Macrophages (CD68 +ve ) immunohistochemistry and quantification (count/mm 2 , biological replicates = 5) and Picrosirius red (PSR) staining of collagen deposition (biological replicates = 6). (C) SARS-CoV-2 nucleocapsid-positive staining regions (arrows) in infected mouse hearts. (D) Cardiac ACE2 immunoblot (1 band) and quantification (biological replicates = 5-7). (E) Cardiac bulk-RNA sequencing principal component analysis (PCA) of genes from mock and day 7 postinfection WT and db/db mice (biological replicates = 5-7). (F) Volcano plots of differentially expressed genes (DEGs) in WT vs db/db mock, WT infected vs mock, db/db infected vs mock, and infected db/db vs infected WT. (G) Apelin ( Apln ), apelin receptor ( Aplnr ), and (H) taurine transporter ( Slc6A6 ) expression levels. (I) Expression levels of SARS-CoV-2 entry-related enzymes: TMPRSS2 ( Tmprss2 ), cathepsin B ( Ctsb ), and furin ( Furin ). (J) Expression pattern of interleukin-34 ( Il34 ), transforming growth factor β ( Tgfb1 ), and inhibitor of kappa B alpha (IκBα) repressor ( Nfkbia ). MemCode protein loading control. FPKM, Fragments Per Kilobase of transcript per Million mapped reads; day 2 and day 7 indicate post-infection mice. Bar plots represent mean ± SD and ANOVA with Tukey post hoc statistical testing B and D, G to J. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001. Representative images shown..

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Infection, Gene Expression, Immunohistochemistry, Staining, Western Blot, Bulk RNA Sequencing, Analysis, Expressing, Control, Significance Assay

    Journal: JACC: Basic to Translational Science

    Article Title: Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

    doi: 10.1016/j.jacbts.2026.101691

    Figure Lengend Snippet:

    Article Snippet: Cells were fixed with 4% paraformaldehyde (5 minutes), permeabilized with methanol (10 minutes), and blocked with 10% donkey serum for 1 hour before incubating with ACE2 (#AF933, R&D Systems) and SARS-CoV-2 nucleocapsid (#BS-41408R, Bioss) antibodies, followed by Alexa Fluor (Thermo Fisher) secondary antibodies.

    Techniques: Liquid Chromatography with Mass Spectroscopy, Tandem Mass Spectroscopy

    Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, ACE2, or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).

    Journal: MedComm

    Article Title: Blocking Extracellular Cyclophilin A‐Mediated Adhesion Protects Against Bacterial Infection

    doi: 10.1002/mco2.71063

    Figure Lengend Snippet: Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, ACE2, or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).

    Article Snippet: Moreover, siRNAs targeting TGFBR2 and ACE2 were purchased from Santa Cruz Biotechnology.

    Techniques: Binding Assay, Analysis, Transfection, Western Blot, Immunoprecipitation, Enzyme-linked Immunosorbent Assay, Negative Control, Blocking Assay, SPR Assay, Generated, Sampling, Infection, Bacteria, Two Tailed Test